Trevi Therapeutics, Inc. (TRVI) Operating Lease, Payments USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Trevi Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2024.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $69 K, a 188% increase year-over-year.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $276 K, a 132% increase year-over-year.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $231 K, a 77.7% increase from 2022.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $130 K, a 6.48% decline from 2021.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $139 K, a 0.73% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $276 K $69 K +$45 K +188% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $231 K $69 K +$34 K +97.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $197 K $69 K +$33 K +91.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $164 K $69 K +$45 K +188% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $119 K $24 K -$11 K -31.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $130 K $35 K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $130 K $36 K +$1 K +2.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $129 K $24 K -$11 K -31.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $140 K $35 K +$1 K +2.94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $139 K $35 K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $139 K $35 K +$12 K +52.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $127 K $35 K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $127 K $34 K -$11 K -24.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $138 K $35 K +$2 K +6.06% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $136 K $23 K -$11 K -32.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $147 K $35 K +$12 K +52.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $135 K $45 K +$10 K +28.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $125 K $33 K +$11 K +50% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $114 K $34 K -$5 K -12.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $119 K $23 K -$7 K -23.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $126 K $35 K +$9 K +34.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $117 K $22 K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $39 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $30 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $26 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.